Capillary physiology and drug delivery in central nervous system lymphomas

Annals of Neurology

Volumn 57, Issue 1, 2005, Pages 136-139

  Warnke, Peter C ^a   Timmer, Jens ^b   Ostertag, Christoph B ^c   Kopitzki, Klaus ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IOPAMIDOL; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY PERMEABILITY; CENTRAL NERVOUS SYSTEM TUMOR; CHEMOSENSITIVITY; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG SOLUBILITY; FEMALE; GLIOBLASTOMA; HUMAN; LYMPHOMA; MALE; MEDULLOBLASTOMA; METASTASIS; PRIORITY JOURNAL; TUMOR BLOOD FLOW; WHITE MATTER;

ADULT; AGED; BRAIN MAPPING; CAPILLARIES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IOPAMIDOL; LYMPHOMA; MALE; MIDDLE AGED; MODELS, THEORETICAL; REGIONAL BLOOD FLOW; TOMOGRAPHY, X-RAY COMPUTED;

EID: 11144241792     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20335     Document Type: Article

References (14)

1. Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003;21:1044-1049.
2. Hoang-Xuan K, Taillandier L, Chinot O, et al. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group. J Clin Oncol 2003;21: 2726-2731.
3. Coulon A, Lafitte F, Hoang-Xuan K, et al. Radiographie findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 2002;12:329-340.
4. Zimmerman RA. Central nervous system lymphoma. Radiol Clin North Am 1990;28:697-721.
5. Groothuis DR, Lapin GD, Vriesendorp FJ, et al. A method to quantitatively measure transcapillary transport of iodinated compounds in canine brain tumors with computed tomography. J Cereb Blood Flow Metab 1991;11:939-948.
6. Fenstermacher JD, Blasberg RG, Patlak CS. Methods for quantifying the transport of drugs across brain barrier systems. Pharmacol Ther 1981;14:217-248.
7. Behrens PF, Ostertag CB, Warnke PC. Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study. Neurosurgery 1998;43:235-241.
8. Ott RJ, Brada M, Flower MA, et al. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991;27:1356-1361.
9. DeAngelis LM, Seiferheld W, Schold SC, et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002;20:4643-4648.
10. Groothuis DR, Blasberg RG. Rational brain tumor chemotherapy. The interaction of drug and tumor. Neurol Clin 1985;3: 801-816.
11. Machein MR, Kullmer J, Fiebich BL, et al. Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 1999;44: 732-741.
12. Miles KA, Kelley BB. CT measurements of capillary permeability within nodal masses: a potential technique for assessing the activity of lymphoma. Br J Radiol 1997;70:74-79.
13. Khan RB, Shi W, Thaler HT, et al. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? J Neurooncol 2002;58:175-178.
14. Herrlinger U, Kuker W, Platten M, et al. First-line therapy with temozolomide induces regression of primary CNS lymphoma. Neurology 2002;58:1573-1574.